Aeglea BioTherapeutics
rethinking the potential of human enzyme therapeutics | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
5 of 28
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
June 2020
rethinking the potential of human enzyme therapeutics | Aeglea BioTherapeutics
Related slides by other companies
Absci
Investor Presentation
March 2023
lead optimization for increased success rates higher potential therapeutics | Absci
MindMed
Results
November 2023
has proven potential across multiple therapeutic areas | MindMed
Absci
Investor Presentation
May 2022
announces research collaboration with | Absci
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
potential advantages in mash | NeuroBo Pharmaceuticals
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io